OKYO Pharma to Present at BIO-Europe 2025 in Vienna
OKYO Pharma Limited - Ordinary Shares (OKYO)
Company Research
Source: GlobeNewswire
LONDON and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that Gary S. Jacob, Ph.D., Chief Executive Officer of OKYO Pharma, will present at the 33rd Annual BIO-Europe partnering conference in Vienna, Austria. BIO-Europe, one of the largest and most impactful international life science partnering events, is scheduled for November 3-5, 2025, at the Vienna Congress and Convention Center, Vienna. Dr. Jacob's presentation will highlight OKYO's lead investigational candidate, urcosimod, and provide updates on the company's recently completed Phase 2 clinical trial for the treatment of NCP. "We are excited to showcase our progress at BIO-Europe, a premier platform for advancing partnerships in the biopharma sector," said Gary S. Jac
Show less
Read more
Impact Snapshot
Event Time:
OKYO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OKYO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OKYO alerts
High impacting OKYO Pharma Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
OKYO
News
- OKYO Pharma Announces Chairman and Founder Acquires SharesGlobeNewswire
- OKYO Pharm Chairman and Founder acquires shares [Seeking Alpha]Seeking Alpha
- OKYO Pharma Announces Chairman and Founder Acquires Shares [Yahoo! Finance]Yahoo! Finance
- OKYO Pharma Announces Chairman and Founder Acquires SharesGlobeNewswire
- OKYO Pharma to Present at OIS XV in San Diego [Yahoo! Finance]Yahoo! Finance
OKYO
Analyst Actions
- 9/23/25 - HC Wainwright
OKYO
Sec Filings
- 12/3/25 - Form 6-K
- 11/21/25 - Form 6-K
- 11/18/25 - Form 6-K
- OKYO's page on the SEC website